US 7220730
Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
granted A61KA61K51/0491A61K51/0493
Quick answer
US patent 7220730 (Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K51/0491, A61K51/0493